Disease Landscape and Forecast Insights

Clarivate Epidemiology’s coverage of pulmonary hypertension (PH) comprises epidemiological estimates of key patient populations in 14 mature and emerging pharmaceutical markets worldwide. We…

Clarivate Epidemiology’s coverage of pulmonary hypertension (PH) comprises epidemiological estimates of key patient populations in 14 mature and emerging pharmaceutical markets worldwide. We…

Clarivate Epidemiology’s coverage of insomnia comprises epidemiological estimates of key patient populations across the Europe pharmaceutical markets. We report the prevalence of insomnia for each…

Clarivate Epidemiology’s coverage of SLE comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the diagnosed prevalence and the diagnosed…

Clarivate Epidemiology’s coverage of OPE comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of OPE for each country, as well as…

Characterized by high incidence and long treatment durations, the breast cancer therapy market represents substantial commercial opportunity for drug developers. CDK4/6 inhibitors (Pfizer’s…

Clarivate Epidemiology’s coverage of OPE comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of OPE for each country, as well as…

Clarivate Epidemiology’s coverage of OPE comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of OPE for each country, as well as…

Clarivate Epidemiology’s coverage of OPE comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of OPE for each country, as well as…

The treatment landscape for COVID-19 continues to evolve rapidly. Even with vaccines having become available in the markets under study, intense ongoing research has also focused on approaches…

Clarivate Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of epilepsy for each country, as…

Clarivate Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of epilepsy for each country, as…